Greylin Investment Mangement Inc Gsk PLC Transaction History

Greylin Investment Mangement Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$42.05 - $47.77 $742,813 - $843,857	17,665 Added 86.21%	38,155 $1.66 Million
Q1 2022 May 20, 2022	BUY	$40.23 - $47.74 $284,224 - $337,283	7,065 Added 52.63%	20,490 $893,000
Q4 2021 Feb 15, 2022	BUY	$38.88 - $45.31 $521,964 - $608,286	13,425 New	13,425 $592,000
Q4 2018 Jan 14, 2019	SELL	$37.8 - $42.69 $193,724 - $218,786	-5,125 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $581,542 - $624,554	-14,630 Reduced 74.06%	5,125 $206,000
Q2 2018 Aug 07, 2018	SELL	$39.61 - $42.76 $399,070 - $430,807	-10,075 Reduced 33.77%	19,755 $796,000
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $1.38 Million - $1.53 Million	-38,195 Reduced 56.15%	29,830 $1.17 Million
Q4 2017 Jan 16, 2018	SELL	$35.34 - $41.9 $1.53 Million - $1.82 Million	-43,385 Reduced 38.94%	68,025 $2.41 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $4.39 Million - $4.63 Million	111,410	111,410 $4.52 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

Stay updated on Greylin Investment Mangement Inc with notifications on news.